middle.news
TrivarX Advances US Mental Health Trial with $2.25m Capital Boost
4:37am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
TrivarX Advances US Mental Health Trial with $2.25m Capital Boost
4:37am on Monday 2nd of June, 2025 AEST
Key Points
Clinical trial approved by US Department of Veterans Affairs Institutional Review Board
Trial to recruit 60 patients using TrivarX’s single-channel ECG algorithm for depression screening
Pre-submission meeting held with US FDA to finalize pivotal study design for MEB-001
Strategic capital raise of $2.25 million strengthens balance sheet
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Trivarx (ASX:TRI)
OPEN ARTICLE